Among BC patients both HMGA1 and stathmin are expressed at high levels in the basal-like and the HER2+ subtypes, ER-negative, and high-grade tumours (Fig. 1C and Supplementary Fig. 1). This evidence concerns the gene ERBB2 and breast cancer.